Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,515 | -47,590 | -26,249 | -85,466 | -34,608 |
| Depreciation Amortization | 4,941 | 5,992 | 5,726 | 4,082 | 4,070 |
| Income taxes - deferred | 10,742 | -5,163 | -5,501 | 1,889 | N/A |
| Accounts receivable | 2,594 | -1,856 | 843 | -1,194 | -3,220 |
| Accounts payable and accrued liabilities | -3,177 | 9,901 | -1,238 | -264 | 2,088 |
| Other Working Capital | -79,560 | -50,412 | 63,900 | 252,151 | -2,655 |
| Other Operating Activity | 23,634 | 16,983 | 28,010 | 25,321 | 9,695 |
| Operating Cash Flow | $-84,341 | $-72,145 | $65,491 | $196,519 | $-24,630 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 22,570 | 23,231 | 28,800 | -261,140 | -25,060 |
| PPE Investments | -4,732 | -4,949 | -10,764 | -5,446 | -4,986 |
| Purchase Of Investment | N/A | -10,000 | -100 | -10,000 | N/A |
| Other Investing Activity | 0 | 6,151 | 0 | -839 | 0 |
| Investing Cash Flow | $17,838 | $14,433 | $17,936 | $-277,425 | $-30,046 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 957 | 4,000 |
| Debt Repayment | N/A | N/A | -6,758 | -3,333 | -2,259 |
| Common Stock Issued | 3,663 | 3,509 | 9,913 | 61,011 | 164,890 |
| Financing Cash Flow | $3,663 | $3,509 | $3,155 | $58,635 | $166,631 |
| Exchange Rate Effect | -29 | -121 | 53 | -527 | 243 |
| Beginning Cash Position | 137,468 | 191,792 | 105,157 | 127,955 | 15,757 |
| End Cash Position | 74,599 | 137,468 | 191,792 | 105,157 | 127,955 |
| Net Cash Flow | $-62,869 | $-54,324 | $86,635 | $-22,798 | $112,198 |
| Free Cash Flow | |||||
| Operating Cash Flow | -84,341 | -72,145 | 65,491 | 196,519 | -24,630 |
| Capital Expenditure | -4,732 | -4,949 | -10,764 | -7,788 | -4,986 |
| Free Cash Flow | -89,073 | -77,094 | 54,727 | 188,731 | -29,616 |